Dynamic avalanching accurately assesses flowability and quality - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Dynamic avalanching accurately assesses flowability and quality
The amount of fine (d10 µm) particles in bulk antibiotics can be a source of problems during the production of finished dosage forms as they can be subjected to forces of agglomeration and/or cohesion, resulting in poor powder flow and non-uniform drug dispersion in a formulation blend.


Pharmaceutical Technology Europe


Cefaclor is a β-lactam cephalosporin antibiotic that has a wide particle size distribution. Because of the nonporous nature of the material, the specific surface area value accounts for a significant amount of fine particles possibly present in the samples under analysis. In light of this, dynamic avalanching measurements were performed on Cefaclor samples characterized by comparable particle size distribution curves, but different specific surface area values.

What is dynamic avalanching?


Table 1: Tested powder samples.
Dynamic avalanching is a technique for investigating powder flow properties under dynamic conditions and has, in the last decade, received growing attention from the scientific community.1,2 Powder avalanching in a rotating drum enables the evaluation of dynamic powder flow characteristics on the basis of deterministic chaos theory.3


Table 2: Fine particle content of the analysed samples.
In the last few years, the commercial availability of automated powder flowability analysers has contributed to the widening acceptance of this analytical technique in the pharmaceutical industry.4,5 The first instrument launched on the market, AeroFlow (TSI Inc. Particle Instruments/Amherst, MA, USA), was based on a rotating plexiglas drum that contained the powder to be tested. The powder movement was monitored by a light and photocell arrangement; the photocell, located behind the drum, collected the light passing through the drum and recorded light variations resulting from cyclic formation of avalanches. Kaye has reported the theoretical basis for this commercial device.3,6,7


Table 3: Specific surface area of the analysed samples.
Because of the limits intrinsic to its own arrangement, AeroFlow has been replaced by the more versatile Revolution powder analyser (Mercury Scientific Inc., SC, USA), which features a more powerful detection system. In this instrument, a video camera, with the assistance of a cold cathode back-light illumination, captures images of the whole powder contained in the drum during the rotation process. With AeroFlow, however, information regarding the powder sample was limited to just a small portion of it.


Table 4: Most conventional flowability descriptors measured after fluidization.
Cefaclor suitability for formulation purposes is assessed on the basis of both particle size distribution data and specific surface area (SSA) values obtained from air permeability measurements. These measurements are essential to discriminate between 'suitable' and 'unsuitable' samples because, as a nonporous material, Cefaclor's SSA values are related to the content of particles with an average diameter in the 0.2–50.0 µm range.8 If these fine particles are present in a significant quantity, then they can negatively affect successive formulation operations.


Figure 1: Overlay of power attractions for sample 1 and sample 4.
In our study, Revolution was used to test the flowability of Cefaclor; the analyses were performed on the samples with similar particle size distribution, but with slightly different fine (≤ 10 µm) particle contents. The aim of the dynamic avalanching measurements was to see if differences among the analysed samples influenced their flowability characteristics and, if so, which among the typical descriptors that can be derived from these measurements (e.g., avalanche time, avalanche power, surface fractal, etc.) was more informative to reveal these differences.


ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
20%
In Western Europe
18%
In Central and Eastern Europe
4%
In Japan
2%
In India
27%
In China
29%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
PhRMA Details Its Proposal for Internet and Social-Media Standards
The Unregulated Regulator
Rx-360 Goals Get off the Ground
US and Europe At Risk from Substandard Medicines
What is Next in Patent Reform?
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here